Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2019

17.10.2018 | Editorial

Endoscopic Management of Cholangiocarcinoma: Putting in Your Two Stents’ Worth

verfasst von: Daniel S. Strand

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

Cholangiocarcinoma (CCA) is an uncommon and locally aggressive malignancy of the biliary epithelium, which presents significant challenges to patients and physicians. Without treatment, most patients with CCA follow a dismal and progressive disease course eventuating in loss of life as a result of cholestatic liver failure, biliary infection, or bleeding [1]. In particular, hilar CCA represents an especially challenging entity with respect to relieving obstructive jaundice due to the intense desmoplastic reaction and local tumor extension into biliary radicals that may separately occlude more than one hepatic lobe, sector, or segment [1]. Due to this infiltrative and sometimes piecemeal pattern of obstruction, achieving meaningful drainage can require technically complex or multiple intervention(s). …
Literatur
3.
Zurück zum Zitat Vienne A, Hobeika E, Gouya H, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72:728–735.CrossRefPubMed Vienne A, Hobeika E, Gouya H, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72:728–735.CrossRefPubMed
4.
Zurück zum Zitat Liberato MJ, Canena JM. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol. 2012;12:103.CrossRefPubMedPubMedCentral Liberato MJ, Canena JM. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol. 2012;12:103.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat De Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–553.CrossRefPubMed De Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–553.CrossRefPubMed
6.
Zurück zum Zitat Sawas T, Al Halabi S, Parsi MA, et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82:256–267.e7.CrossRefPubMed Sawas T, Al Halabi S, Parsi MA, et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82:256–267.e7.CrossRefPubMed
7.
Zurück zum Zitat Al-Kawas F, Aslanian H, Baillie J, et al. Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial. Trials. 2018;19:108.CrossRefPubMedPubMedCentral Al-Kawas F, Aslanian H, Baillie J, et al. Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial. Trials. 2018;19:108.CrossRefPubMedPubMedCentral
Metadaten
Titel
Endoscopic Management of Cholangiocarcinoma: Putting in Your Two Stents’ Worth
verfasst von
Daniel S. Strand
Publikationsdatum
17.10.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5337-4

Weitere Artikel der Ausgabe 2/2019

Digestive Diseases and Sciences 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.